Skip to main content
Premium Trial:

Request an Annual Quote

Industrial Genomics Firm, Sequenom, Files for IPO

Premium

SAN DIEGO--The industrial genomics and bioinformatics company Sequenom announced last week that it had filed with the Securities and Exchange Commission for a public offering of common stock. The offering was led by Warburg Dillon Read, with assistance from Robertson Stephens and SG Cowen. The underwriters will be granted a 30-day over-allotment option to purchase additional shares of common stock from the company.

Sequenom's MassArray system combines proprietary enzymology and bioinformatics in a miniaturized chip-based format with mass spectrometry.

Proceeds of the offering will be used to hire additional sales and support personnel, expand its facilities, continue to develop and manufacture existing products, research and develop additional products, and to prosecute patents. Funds could also be used to acquire products, technologies, or companies, and to repay long-term debt and accrued interest of approximately $4.2 million, the company said.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.